This model, which includes ANLN, effectively predicts the survival outcomes of cervical cancer patients, with a high degree of accuracy for 1-, 5-, 10-, and 15-year survival rates (AUC>0.7) (Li et al., 2021). The gene discussed is ANLN; the disease is cervical carcinoma.